Duksung Past Earnings Performance
Past criteria checks 5/6
Duksung has been growing earnings at an average annual rate of 32.4%, while the Chemicals industry saw earnings growing at 12.4% annually. Revenues have been growing at an average rate of 8% per year. Duksung's return on equity is 6.6%, and it has net margins of 5.2%.
Key information
32.4%
Earnings growth rate
32.4%
EPS growth rate
| Chemicals Industry Growth | 13.9% |
| Revenue growth rate | 8.0% |
| Return on equity | 6.6% |
| Net Margin | 5.2% |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
Is Duksung (KRX:004830) Using Too Much Debt?
Mar 20
Duksung Co., Ltd.'s (KRX:004830) 27% Share Price Surge Not Quite Adding Up
Feb 28Duksung (KRX:004830) Is Doing The Right Things To Multiply Its Share Price
Feb 27Here's Why Duksung (KRX:004830) Can Manage Its Debt Responsibly
Mar 13Will Duksung's (KRX:004830) Growth In ROCE Persist?
Feb 14
The Duksung (KRX:004830) Share Price Is Up 150% And Shareholders Are Boasting About It
Jan 18Duksung Co., Ltd.'s (KRX:004830) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock?
Dec 23These 4 Measures Indicate That Duksung (KRX:004830) Is Using Debt Reasonably Well
Nov 27Revenue & Expenses BreakdownBeta
How Duksung makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 107,933 | 5,634 | 9,861 | 1,290 |
| 30 Sep 23 | 109,603 | 2,133 | 9,699 | 1,385 |
| 30 Jun 23 | 117,044 | 2,301 | 10,581 | 1,422 |
| 31 Mar 23 | 123,586 | 1,805 | 11,078 | 1,517 |
| 31 Dec 22 | 133,298 | 2,515 | 10,307 | 1,590 |
| 30 Sep 22 | 136,933 | 6,015 | 10,249 | 1,580 |
| 30 Jun 22 | 131,039 | 5,574 | 9,119 | 1,598 |
| 31 Mar 22 | 125,668 | 5,219 | 8,623 | 1,636 |
| 31 Dec 21 | 115,177 | 5,923 | 8,519 | 1,596 |
| 30 Sep 21 | 109,607 | 4,374 | 8,201 | 1,564 |
| 30 Jun 21 | 119,317 | 5,447 | 8,363 | 1,532 |
| 31 Mar 21 | 116,092 | 5,080 | 8,606 | 1,487 |
| 31 Dec 20 | 117,682 | 3,622 | 8,725 | 1,462 |
| 30 Sep 20 | 114,931 | 4,119 | 8,880 | 1,403 |
| 30 Jun 20 | 100,319 | 2,465 | 8,739 | 1,393 |
| 31 Mar 20 | 95,151 | 1,706 | 8,255 | 1,439 |
| 31 Dec 19 | 86,727 | 185 | 8,300 | 1,406 |
| 30 Sep 19 | 83,214 | -708 | 7,997 | 1,407 |
| 30 Jun 19 | 82,282 | -859 | 7,606 | 1,363 |
| 31 Mar 19 | 81,770 | -1,248 | 7,813 | 1,248 |
| 31 Dec 18 | 83,746 | -2,022 | 7,556 | 1,232 |
| 30 Sep 18 | 83,252 | -2,733 | 7,793 | 1,111 |
| 30 Jun 18 | 85,857 | -1,473 | 7,943 | 1,193 |
| 31 Mar 18 | 93,442 | -847 | 8,304 | 1,191 |
| 31 Dec 17 | 100,706 | 523 | 8,060 | 1,227 |
| 30 Sep 17 | 105,196 | 2,577 | 8,718 | 876 |
| 30 Jun 17 | 107,554 | 1,950 | 8,421 | 943 |
| 31 Mar 17 | 107,532 | 2,972 | 8,014 | 1,058 |
| 31 Dec 16 | 103,809 | 2,942 | 8,152 | 1,088 |
| 30 Sep 16 | 97,227 | 1,575 | 7,496 | 1,492 |
| 30 Jun 16 | 91,062 | 1,489 | 7,598 | 1,325 |
| 31 Mar 16 | 82,659 | 849 | 7,532 | 1,275 |
| 31 Dec 15 | 76,938 | 522 | 7,113 | 1,229 |
| 30 Sep 15 | 79,132 | 1,497 | 7,033 | 1,344 |
| 30 Jun 15 | 77,147 | 1,118 | 7,121 | 1,365 |
| 31 Mar 15 | 78,602 | 97 | 7,053 | 1,301 |
| 31 Dec 14 | 82,288 | 760 | 7,553 | 1,338 |
| 30 Sep 14 | 86,551 | 1,239 | 7,763 | 1,228 |
| 30 Jun 14 | 92,183 | 1,731 | 7,607 | 1,236 |
| 31 Mar 14 | 100,179 | 4,167 | 7,682 | 1,231 |
| 31 Dec 13 | 97,419 | 4,383 | 7,335 | 1,176 |
| 30 Sep 13 | 96,608 | 3,187 | 7,571 | 1,219 |
| 30 Jun 13 | 100,446 | 4,453 | 7,499 | 1,200 |
Quality Earnings: A004830 has high quality earnings.
Growing Profit Margin: A004830's current net profit margins (5.2%) are higher than last year (1.9%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: A004830 has become profitable over the past 5 years, growing earnings by 32.4% per year.
Accelerating Growth: A004830's earnings growth over the past year (124%) exceeds its 5-year average (32.4% per year).
Earnings vs Industry: A004830 earnings growth over the past year (124%) exceeded the Chemicals industry -15.5%.
Return on Equity
High ROE: A004830's Return on Equity (6.6%) is considered low.